跳至主要内容
临床试验/NCT03549741
NCT03549741Unknown2 期

Cabergoline As An Adjuvant To Clomiphene Citrate For Management Of Unexplained Infertility: Randomized Controlled Trial

Assiut University0 个研究点目标入组 120 人开始时间: 2018年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
120
主要终点
The number of mature follicles

研究概览

简要总结

Infertility refers to an inability to conceive after having regular unprotected sex. Infertility can also refer to the biological inability of an individual to contribute to conception, or to a female who cannot carry a pregnancy to full term. In many countries infertility refers to a couple that has failed to conceive after 12 months of regular sexual intercourse

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
20 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • unexplained infertility, Primary or secondary.
  • Absence of galactorrhoea.
  • Normal serum prolactin.
  • Normal hysterosalpingography.
  • Normal spermogram.

排除标准

  • Women on other line of treatment as aromatase inhibitors,gonadotrophins, or tamoxifen.
  • Known hypersensitivity for cabergoline or clomiphene citrate.
  • Other factors of infertility as tubal factor, uterine factor or male factor.

研究组 & 干预措施

study group

Experimental

will receive a dose of Clomiphene citrate 50 mg tablet , 1 tab twice daily for 5 days from the third day of menses to the seven day and cabergoline 0.25 mg (half tablet) every 3 days (one package) first three months then Clomiphene citrate 50 mg tablet , 2 tabs twice daily for 5 days from the third day of menses to the seven day and cabergoline 0.25 mg (half tablet) every 3 days (one package)

干预措施: Clomiphene Citrate 50mg (Drug)

study group

Experimental

will receive a dose of Clomiphene citrate 50 mg tablet , 1 tab twice daily for 5 days from the third day of menses to the seven day and cabergoline 0.25 mg (half tablet) every 3 days (one package) first three months then Clomiphene citrate 50 mg tablet , 2 tabs twice daily for 5 days from the third day of menses to the seven day and cabergoline 0.25 mg (half tablet) every 3 days (one package)

干预措施: Cabergoline Oral Tablet (Drug)

control group

Active Comparator

will receive a dose of Clomiphene citrate and placebo tablets with same dose and duration

干预措施: Clomiphene Citrate 50mg (Drug)

control group

Active Comparator

will receive a dose of Clomiphene citrate and placebo tablets with same dose and duration

干预措施: Placebo Oral Tablet (Drug)

结局指标

主要结局

The number of mature follicles

时间窗: 14 days

the follicles reach the size of 18 mm

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Abdeltawab Mhanny

Principal investigator

Assiut University

相似试验